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Abstract
Objective—To assess the contribution of neurocysticercosis (NCC) to the burden of epilepsy in a 
rural Tanzanian population.
Methods—We identified adult people with epilepsy (PWE) in a door-to-door study in an 
established demographic surveillance site. PWE and community controls were tested for 
antibodies to Taenia solium, the causative agent of NCC, and all PWE were offered a computed 
tomography (CT) head scan. Data on household occupancy and sanitation, pig-keeping and pork 
consumption were collected from PWE and controls and associations with epilepsy were assessed 
using chi-square or Fisher’s exact tests.
Results—Six of 218 PWE had antibodies to T. solium (2.8%; 95% CI 0.6–4.9), compared to 
none of 174 controls (Fisher’s exact test, P = 0.04). Lesions compatible with NCC were seen in 
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eight of 200 CT scans (4.0%; 95% CI 1.3–6.7). A total of 176 PWE had both investigations of 
whom two had positive serology along with NCC-compatible lesions on CT (1.1%; 95% 0.3–4.0). 
No associations between epilepsy and any risk factors for NCC were identified.
Conclusions—Neurocysticercosis is present in this population but at a lower prevalence than 
elsewhere in Tanzania and sub-Saharan Africa. Insights from low-prevalence areas may inform 
public health interventions designed to reduce the burden of preventable epilepsy.
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Introduction
Taenia solium, the causative agent of human cysticercosis, is the commonest helminthic 
infection of the central nervous system worldwide [1] and is recognised as a leading cause of 
adult-onset epilepsy in endemic areas. Globally, up to 50 million people may be affected by 
cysticercosis [2] and up to 30% of all epilepsy may be associated with neurocysticercosis 
(NCC) [3]. Taenia solium carriage in human populations is perpetuated by two main factors: 
a pig population that is frequently exposed to human faecal matter (usually through free-
range pig-keeping), and insufficient food hygiene at the meat inspection and/or food 
preparation stages that leads to consumption of undercooked encysted pork. When such 
circumstances prevail, the additional risk of human cysticercosis arises through faecal–oral 
exposure to Taenia eggs in environments where sanitation is poor [4]. Following ingestion of 
Taenia eggs extraintestinal tissues may become infected with the encysted larval stage and 
involvement of parenchymal brain tissue (i.e. neurocysticercosis) may lead to epilepsy [5].
The diagnosis of NCC can be difficult, with non-specific clinical manifestations (seizures, 
headaches, focal neurological deficits) and imaging findings that are often abnormal but 
seldom pathognomonic [6–8]. Serological tests using enzyme-linked immunosorbent assays 
(ELISA) or enzyme-linked immunotransfer blot (EITB) are available. Although these have 
sensitivities of 70–90% in experimental conditions [9–11], they may be less sensitive in 
patients with single lesions [7, 12], or less specific in highly endemic regions where 10% or 
more of the general population may have antibodies to T. solium, reflecting prior exposure 
as well as active infection or disease [13, 14]. When seeking to diagnose NCC serology 
should therefore be correlated with imaging findings wherever possible. In recognition of 
these difficulties diagnostic criteria have been developed that incorporate imaging, 
serological, clinical and epidemiological factors to arrive at diagnoses characterised as either 
definitive or probable NCC [15].
While NCC is considered to be the leading preventable cause of epilepsy in low- and 
middle-income countries, population-level data from sub-Saharan Africa (SSA) are 
relatively few. A systematic review identified 13 studies from eight countries conducted 
between 1989 and 2009 [1], 11 of which were suitable for inclusion in a meta-analysis 
which estimated a common odds ratio for developing epilepsy when cysticercosis was 
present of between 2.7 and 4.3 [16]. Only two studies from SSA outside of South Africa, 
both from Tanzania, have presented both imaging and serological findings to investigate the 
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burden of cysticercosis/NCC among people with epilepsy (PWE). In northern Tanzania 
17.9% of 212 PWE originally identified in a community-based study of epilepsy [17] had 
radiological evidence of NCC [18] and anticysticercal antibodies were subsequently detected 
by EITB in 28.4% of a subset of 81 PWE from the same study [19]. In southern Tanzania a 
community-based cross-sectional sero-prevalence study of human T. solium infection found 
that 53.7% of 123 people reporting epileptic seizures had anticysticercal antibodies detected 
by ELISA [20]. In the same study 28 people reporting seizures who had positive cysticercal 
antigen ELISA went on to have CT brain scans, all of whom had radiological evidence of 
NCC.
The aim of our study was to investigate the contribution of NCC to the burden of active 
convulsive epilepsy (ACE) in an adult population of rural northern Tanzania in which this 
issue has not previously been investigated. Exposure to T. solium among PWE and controls 
was determined serologically and neuroimaging in PWE was used to look for radiological 
evidence of NCC.
Methods
Study setting
The Hai district lies on the slopes of Mount Kilimanjaro in north-east Tanzania, covering an 
area of approximately 1300 km2. Agriculture, livestock keeping (including pig-keeping), 
dairy farming, commercial mining and cottage industries are the main economic activities 
[21]. Computed tomography (CT) is available locally at Kilimanjaro Christian Medical 
Centre (KCMC), a large referral hospital in the nearby town of Moshi. Hai was originally 
established as a demographic surveillance site (DSS) in Tanzania by the Adult Morbidity 
and Mortality Project, an epidemiological programme conducted in partnership between the 
Tanzanian Ministry for Health and Newcastle University, United Kingdom [22]. The Hai 
DSS is comprised of 59 villages with a total population of 161 119 following the most recent 
census conducted in 2009 [23].
Participants and study design
Adult PWE were identified following a door-to-door census of the Hai DSS population 
during which a previously validated screening questionnaire to detect possible cases of 
epilepsy was administered [23]. After confirmation of epilepsy diagnoses by the research 
doctor (EH) all PWE were offered CT imaging of the brain and asked for a blood sample to 
be tested for antibodies to T. solium. All seizures and epilepsies were classified according to 
currently accepted criteria [24].
For each PWE contributing a blood sample six age-, sex- and village-matched controls were 
identified by random number sequence from the census database used in the prevalence 
study. Individuals from each group of six were approached in turn until one agreed to 
participate in the study. All controls were also asked for a blood sample; demographic data 
on age, sex, ethnic group, religion, educational level, household occupancy, domestic 
sanitation, pork consumption and pig-keeping were collected from all PWE and controls.
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Imaging and serology
CT scans were done at KCMC using a Philips Tomoscan 4000 single-slice spiral scanner. 
Pre- and post-contrast scans were performed with 10-mm-thick slices. All CT scans were 
reviewed locally by a consultant radiologist (AJ) to exclude any pathology requiring 
immediate further investigation or management and subsequently reviewed in the United 
Kingdom by two neuroradiologists (AI and DB). Blood samples were analysed at the 
KEMRI-Wellcome research laboratory in Kilifi, Kenya, for the presence of anticysticercal 
antibodies. A Western blot assay utilising recombinant T. solium antigens to detect 
antibodies to cysticercosis (rT24H antigen) and taeniasis (rES33 antigen) was used. This 
technique is 97.0% sensitive and 99.4% specific for detection of NCC with two or more 
cysts, and 99.4% sensitive and 93.9% specific for detection of taeniasis [25]. For comparison 
of serology results a sample size of 134 cases and controls (total sample 268) was required 
to detect an odds ratio of 4.6 with 80% power and 5% significance level, based on data 
derived from a community-based case–control study of cysticercosis and epilepsy performed 
in Burundi [26].
Diagnoses of NCC in our study were made based on a combination of clinical, serological 
and radiological findings, according to accepted diagnostic criteria [15]. We anticipated that 
cysticercosis would be present in the Hai DSS population, as elsewhere in Tanzania, due to a 
number of epidemiological factors. Firstly, the majority of adults identified in the prevalence 
study (71.5%) suffered from focal-onset seizures, suggesting a considerable burden of 
acquired or late-onset epilepsy [23]. Secondly, the 2009 census identified 2270 of 43 794 
(5.2%) households that kept pigs. Smallholder livestock production such as that seen in Hai 
district is associated with poor animal husbandry practice [27] and although we found no 
contemporary data on porcine cysticercosis in the Kilimanjaro region, post-mortem 
examination of pigs in an abattoir in the nearby town of Moshi had previously demonstrated 
the presence of T. solium metacestodes in 6.9% of local pigs [28].
Statistical analysis
Data were analysed using the Statistical Package for Social Sciences (SPSS) version 19. 
Categorical variables were compared using the chi-square test where all expected cell values 
were greater than five; Fisher’s exact test or the likelihood ratio were used for smaller 
expected cell numbers. Ninety-five per cent confidence intervals were calculated using the 
standard error of a proportion based on the binomial distribution. Non-normally distributed 
continuous variables were compared using the Mann–Whitney U-test. Comparisons between 
groups were restricted to those in whom serology was available.
Ethics
The ethics review committee of the Tanzanian National Institute of Medical Research 
approved the study. Informed consent was obtained from all PWE and controls participating 
in the study.
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Results
Recruitment and blood sampling
Blood samples were obtained from 231 of the 291 PWE (79.4%) identified during the 
prevalence study. Of the 60 PWE without blood samples, 57 (95%) had either refused or 
were not available on blood sampling days and two (3.3%) had died since initial 
ascertainment. These individuals were similar to those in whom samples were available in 
terms of age (Mann–Whitney U-test = 6570.5, z = −0.619, P = 0.54) and sex (χ2(1) = 0.091, 
P = 0.76). We encountered a high refusal rate during recruitment, meaning that 1:1 and 
geographic matching were not achieved as intended. A total of 182 controls were finally 
included in the study, all of whom consented to give a blood sample, and 78.8% of 231 PWE 
who gave blood samples were matched to controls, these being drawn from 49 of the 54 
villages (90.7%) in which PWE were identified. A total of 413 blood samples were 
collected, of which 21 (5.1%) were either damaged or insufficient and not suitable for 
analysis: 13 (5.6%) of 231 PWE and 8 (4.5%) of 182 controls (χ2(1) = 0.32, P = 0.57). A 
total of 392 samples were therefore analysed: 218 from PWE and 174 from controls (Figure 
1). Among those with serology results available, PWE were younger than controls (median 
age 31 vs. 39 years, U = 15833.0, z = −2.812, P = 0.005), and fewer PWE than controls had 
completed primary education (52.9% vs. 77.5%; χ2(1) = 24.621 P < 0.001). Other 
demographic features were similarly distributed among the two groups (Table 1).
Serology results
Antibodies to T. solium were identified in 6 (2.8%) of 218 PWE and 0 (0%) of 174 controls. 
Of the six seropositive PWE three (50%) had antibodies to the T24 antigen only, one 
(16.7%) had antibodies to the ES33 antigen only and two (33.3%) had antibodies to both 
antigens. The overall seroprevalence of T. solium antibodies among PWE was 2.8% (95% CI 
0.6–4.9) and there was weak evidence of an association between seropositivity and having 
epilepsy (Fisher’s exact test, P = 0.04). Possible domestic and dietary risk factors for 
taeniasis and/or cysticercosis were compared between PWE and controls, with no significant 
associations being identified (Table 1).
Imaging results
CT head scans were available from 200 of 291 PWE (68.7%): 106 males (53.0%) and 94 
females (47.0%). The proportions of males and females were similar between PWE who did 
and did not have a CT scan (χ2(1) = 0.18, P = 0.89), although PWE who did have scans 
were older than those who did not (median age 32 vs. 26 years; U = 10 466.5, z = 2.054, P = 
0.04). Lesions compatible with NCC were seen in 8 (4.0%) of 200 scans, with evidence of a 
greater frequency among females than males (7 (7.4%) of 94 females vs. 1 (0.9%) of 106 
males; Fisher’s exact test P = 0.03). There were no instances of viable cysts requiring 
antihelminthic treatment or of any other radiological findings warranting acute intervention. 
Radiological abnormalities were seen in 51 scans overall (25.5%), with the most frequent 
finding other than NCC being evidence of cerebrovascular disease, seen in 13 cases (6.5% of 
scans). Other findings included previous trauma, encephalomalacia, hydrocephalus, tumour 
and porencephalic cyst. These and other radiological findings have been published elsewhere 
[23]. CT scans were not obtained in 91 PWE due to refusal or unavailability of PWE to 
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travel to hospital for imaging (60 cases), the scanner not working on some study days (29 
cases) or death since initial ascertainment (2 cases).
A total of 12 PWE had abnormal CT scans and/or positive serology; their demographic, 
clinical, radiological and serological characteristics are summarised in Table 2. All but one 
of these individuals had seizures that could be classified as focal in onset on clinical grounds 
alone, in advance of any investigation results. With regard to treatment, 10 (83.3%) stated 
they were using antiepileptic drugs (AEDs) at the time of initial assessment (seven using 
phenobarbitone, one using carbamazepine and two using phenobarbitone and phenytoin in 
combination), with only one reporting full control of their seizures on AEDs. All PWE 
identified in the study were either started on AEDs or given advice to optimise their therapy. 
The cohort remains under follow-up and it may be possible to examine the response to AED 
therapy of PWE with and without NCC in due course.
A total of 176 PWE underwent both investigations (CT and serology). Within this group six 
cases (3.4%) had lesions on CT compatible with NCC of whom two (33.3%) also had 
positive serology, giving a prevalence of definitive NCC among investigated PWE of 1.1% 
(95% CI 0.3–4.0).
Discussion
Neurocysticercosis is present in the Hai DSS with 4.0% of PWE having evidence of NCC on 
neuroimaging and 1.1% of fully investigated individuals having definitive NCC. The overall 
prevalence of individuals with anticysticercal antibodies, however, is markedly lower than in 
other areas of SSA where up to one-third of the general population may be seropositive, 
rising to nearly 60% among PWE [16, 29].
Within Tanzania two studies have identified higher proportions of individuals with positive 
serology and/or neuroimaging than those seen in Hai. In northern Tanzania Winkler et al. 
[30] found anticysticercal antibodies in 30% of 20 PWE who had NCC on CT scans and in 
none of 20 PWE without NCC (overall seroprevalence in PWE of 15%). No antibodies were 
detected in sera from 20 healthy controls. In an imaging study conducted in the same 
population, 17.9% of 212 PWE were found to have lesions either definitive for or 
compatible with NCC on CT scanning [18]. In the same study, 5.1% of 198 consecutive CT 
head scans performed for various clinical indications in people without epilepsy were also 
found to have evidence of NCC.
A more recent study of the prevalence and risk factors for T. solium infection conducted in 
the Southern Highlands of Tanzania found 45.3% of 830 individuals tested to be antibody-
positive and 16.7% to be antigen-positive [20]. Contrast-enhanced CT scans were performed 
in 55 antigen-positive individuals, with 54.6% of these having evidence of NCC. Although 
this study was not designed to specifically examine the relationship between T. solium and 
epilepsy in this population, a history of seizures was obtained from 14.8% of the study 
population, with diagnoses of epilepsy being based on a questionnaire designed to collect 
information on human cysticercosis. The questionnaire was administered by a nurse, with no 
further discussion with a physician or neurologist, and the extraordinarily high prevalence of 
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epilepsy reported suggests that this screening method had a very low specificity. 
Furthermore, the authors describe partial seizures as being distinct from epileptic seizures, 
by which they perhaps mean to refer to generalised seizures, and report a higher prevalence 
still of 50.8%. Bearing these limitations in mind, antibody- and antigen-positivity among 
people considered to have epilepsy were 53.7% and 22.8% respectively, and all 28 people in 
this group with positive antigen serology were found to have NCC on CT scanning.
Authors from both of these studies comment on local animal husbandry practice and sanitary 
conditions, describing the presence of free-range pig-keeping, limited access to household 
sanitation and safe water and poor hand-washing practice.
In contrast to previous studies pointing to a higher burden of NCC in SSA than that seen in 
the Hai DSS, a comprehensive multisite study conducted across five countries (Ghana, 
Kenya, South Africa, Tanzania and Uganda) has recently reported on the prevalence of ACE 
and its risk factors [31, 32]. Among adults tested at two of the sites (Tanzania and Ghana), T. 
solium antibodies were found in 3.4% of 290 PWE and 1.9% of 421 controls (OR 1.98; 95% 
CI 0.72–5.43). Within the Tanzanian site (Ifakara), the seroprevalence rates among cases and 
controls were 2.9% and 0.3%, respectively (OR 15.42; 95% CI 1.84–129.10), the 
seropositive rate among PWE being similar to our findings from the Hai region. The same 
research group has also reported on the individual and combined association between 
multiple parasitic infections and ACE, based on serological markers [33]. A total of 986 
PWE and 1313 controls were studied across the five sites, with exposure to Onchocerca 
volvulus, Toxocara canis and Toxoplasma gondii being associated with an increased 
prevalence of ACE. In the Hai DSS, the proportion of adult PWE with clinically apparent 
focalonset seizures was high at 71.5% [23]. The majority of these remain unexplained, with 
brain lesions visible on CT, including NCC, being seen in only 25.5% of scans and only a 
limited contribution from T. solium to the burden of epilepsy in this population having been 
demonstrated. Further investigation for other parasitic causes of acquired epilepsy in this 
population would therefore be of interest.
While NCC appears to be an important cause of epilepsy in parts of SSA, the picture is not 
uniform and detailed assessments of the socio-economic and environmental circumstances in 
which different communities live will be necessary to inform any public health interventions 
designed to tackle this issue. At least some of the potential risk factors for cysticercosis are 
present in the Hai DSS (pig-keeping, pork consumption, limited sanitation), although no 
significant associations with epilepsy were found. Possible factors contributing to the low 
prevalence of NCC (and possibly of epilepsy) may be the employment of zero-grazing 
animal husbandry techniques observed in the district, whereby animals are kept penned and 
fodder brought to them (Figure 2), the quality of meat inspection and food preparation 
locally, or the source of pork that is consumed within the district. Further investigation of 
such factors in this population are warranted, in order to understand the presence of the 
small number of cases of taeniasis and NCC identified in an environment where pig 
husbandry is potentially compatible with an absence of local transmission and to provide 
insights that may contribute to the prevention of NCC and, therefore, of epilepsy in areas of 
higher endemicity.
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To diagnose NCC in PWE from the Hai DSS we combined clinical, serological and imaging 
findings according to diagnostic criteria that have previously been used in Africa [15, 18]. 
The prevalence of NCC on imaging in our cohort of PWE was 4.0%, and the WB serology 
used detected these cases with a sensitivity of only 33.3%, considerably lower than that seen 
with ELISA antibody serology in an endemic area of South Africa (54.5%), where the 
prevalence of NCC in PWE on CT imaging was 37% [34]. In the only other study from SSA 
outside of South Africa to correlate imaging and serology specifically to diagnose NCC in 
PWE, the sensitivity of serology for NCC on imaging varied between two different assays: 
52.2% for EITB compared with 13.3% for WB [19]. The use of different assays makes the 
comparison of different studies difficult, with sensitivity varying widely according to assay 
and epidemiological context [10]. In addition, antigenic differences between different T. 
solium genotypes have been described [35], and these may influence both clinical 
presentation and diagnostic accuracy of serological tests [1, 16]. Based on our experience in 
Hai, we support the position that while serological screening has a value in defining the 
baseline prevalence of cysticercosis, it is not clinically useful in populations of low 
endemicity for T. solium or where neuroimaging is not available routinely [36].
There are some limitations to our study. While all socio-demographic data were collected 
from controls under supervision from the research doctor (EH), some these data were 
collected from PWE independently by field workers during the follow-up phase of the 
prevalence study, when patients were attending a local hospital for investigations. Non-
attendance and other operational difficulties meant that these data were incomplete from 
nearly half of PWE overall (44.3%) and it is not clear what biases this may have introduced. 
A high refusal rate among potential controls meant that 1:1 and geographic matching were 
not achieved as intended. This may have led to an underestimation of the prevalence of 
seropositivity in the control group and thus an overestimation of the weak statistical 
association between seropositivity and epilepsy that was observed. For ethical and logistical 
reasons there was no control series of CT scans for comparison. Finally, the initial 
prevalence study only identified PWE with convulsive epilepsy, whether focal or generalised 
in onset. More subtle focal-onset seizures without secondary generalisation which were not 
detected by the study may also be due to acquired brain lesions such as NCC and so the true 
aetiological contribution of NCC to the burden of epilepsy in this population may be higher.
Summary and conclusions
Cysticercosis and NCC are present in the Hai DSS in northern Tanzania but at a low 
prevalence. Further study of the social and environmental factors that distinguish the Hai 
DSS from other areas of Tanzania and SSA where NCC is more highly endemic may help to 
target public health initiatives designed to reduce the burden of acquired epilepsy. 
Serological screening of PWE for cysticercal antibodies has a low sensitivity for identifying 
individuals with evidence of NCC on CT scanning in this population and therefore has 
limited utility in this setting beyond providing baseline estimates of exposure.
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Figure 1. 
Sources of blood samples analysed for Taenia solium antibodies.
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Figure 2. 
Zero-grazing pig husbandry in Hai.
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Table 1
Comparison of demographic features and risk factors for taeniasis/cysticercosis among people with epilepsy 
(PWE) and controls with available serology
PWE (N = 218) n (%)* Controls (N = 174) n (%)* Statistical test
Age (years) Median (IQR) 31.0 (23–45) 39.0 (25–50) Mann–Whitney U-test = 15833.0
z = −2.812
P = 0.005
Sex Males 117 (53.7)   79 (45.4) χ2(1) = 2.646
Females 101 (46.3)   95 (54.6) P = 0.104
Tribe Chagga 173 (80.8) 142 (83.0) χ2(1) = 0.309
Other   41 (19.2)   29 (17.0) P = 0.578
Religion Christian 175 (81.4) 143 (82.7) χ2(1) = 0.104
Muslim   40 (18.6)   30 (17.3) P = 0.748
1° Education Complete 109 (52.9) 134 (77.5) χ2(1) = 24.621
None/incomplete   97 (47.1)   39 (22.5) P < 0.001
No. household occupants Median (IQR)     5 (3–6)     5 (4–7) U = 13 685.0
z = 1.530
P = 0.126
Keeps pigs Yes   17 (8.9)   11 (6.3) χ2(1) = 0.829
No 175 (91.1) 163 (93.7) P = 0.363
Eats pork Yes   72 (49.7)   85 (49.7) χ2(1) < 0.001
No   73 (50.3)   86 (50.3) P = 0.993
Main water source Piped/borehole 121 (82.9) 126 (75.0) χ2(1) = 2.887
River/open source   25 (17.1)   42 (25.0) P = 0.089
Domestic sanitation Indoor toilet     5 (3.4)   10 (5.8) Likelihood ratio(2) = 1.043
Pit latrine 138 (95.2) 159 (93.0) P = 0.594
No provision     2 (1.4)     2 (1.2)
*Column totals within categories differ from N due to missing data.
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